Measurement of anti-influenza neuraminidase antibody using a peroxidase-linked lectin and microtitre plates coated with natural substrates.
about
Eurasian-origin gene segments contribute to the transmissibility, aerosol release, and morphology of the 2009 pandemic H1N1 influenza virusMolecular basis for broad neuraminidase immunity: conserved epitopes in seasonal and pandemic H1N1 as well as H5N1 influenza virusesExpression and Characterization of Recombinant, Tetrameric and Enzymatically Active Influenza Neuraminidase for the Setup of an Enzyme-Linked Lectin-Based AssayH7N9 Live Attenuated Influenza Vaccine Is Highly Immunogenic, Prevents Virus Replication, and Protects Against Severe Bronchopneumonia in Ferrets.Pre-existing cross-reactive antibodies to avian influenza H5N1 and 2009 pandemic H1N1 in US military personnelDevelopment and pre-clinical evaluation of two LAIV strains against potentially pandemic H2N2 influenza virus.Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.Comparability of neuraminidase inhibition antibody titers measured by enzyme-linked lectin assay (ELLA) for the analysis of influenza vaccine immunogenicityInfluenza immunology evaluation and correlates of protection: a focus on vaccines.Immunization with 1976 swine H1N1- or 2009 pandemic H1N1-inactivated vaccines protects mice from a lethal 1918 influenza infectionEvolutionary pathways of the pandemic influenza A (H1N1) 2009 in the UKRevisiting the 1976 "swine flu" vaccine clinical trials: cross-reactive hemagglutinin and neuraminidase antibodies and their role in protection against the 2009 H1N1 pandemic virus in mice.The 2009 pandemic H1N1 virus induces anti-neuraminidase (NA) antibodies that cross-react with the NA of H5N1 viruses in ferretsThe consortium for the standardization of influenza seroepidemiology (CONSISE): a global partnership to standardize influenza seroepidemiology and develop influenza investigation protocols to inform public health policy.Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase.Evaluation of in vitro cross-reactivity to avian H5N1 and pandemic H1N1 2009 influenza following prime boost regimens of seasonal influenza vaccination in healthy human subjects: a randomised trialCarbohydrate biopolymers enhance antibody responses to mucosally delivered vaccine antigens.A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects.Serologic assays for influenza surveillance, diagnosis and vaccine evaluation.Fast vaccine design and development based on correlates of protection (COPs).Comparison of serum hemagglutinin and neuraminidase inhibition antibodies after 2010-2011 trivalent inactivated influenza vaccination in healthcare personnel.Influenza vaccine effectiveness in households with children during the 2012-2013 season: assessments of prior vaccination and serologic susceptibility.An Innovative Pseudotypes-Based Enzyme-Linked Lectin Assay for the Measurement of Functional Anti-Neuraminidase Antibodies.Influenza neuraminidase.Overview of Serological Techniques for Influenza Vaccine Evaluation: Past, Present and Future.Collectin-mediated antiviral host defense of the lung: evidence from influenza virus infection of miceContribution of antibody production against neuraminidase to the protection afforded by influenza vaccines.Generation of a reassortant avian influenza virus H5N2 vaccine strain capable of protecting chickens against infection with Egyptian H5N1 and H9N2 viruses.Randomized comparative study of the serum antihemagglutinin and antineuraminidase antibody responses to six licensed trivalent influenza vaccines.Influenza virus neuraminidase: structure and function.Immunological assessment of influenza vaccines and immune correlates of protection.Correlates of Protection against Influenza in the Elderly: Results from an Influenza Vaccine Efficacy Trial.Influenza A virus hemagglutinin specific antibodies interfere with virion neuraminidase activity via two distinct mechanisms.Measuring Influenza Neuraminidase Inhibition Antibody Titers by Enzyme-linked Lectin Assay.Cross-reactive Antibodies against avian influenza virus A (H5N1).Immune correlates of protection against influenza: challenges for licensure of seasonal and pandemic influenza vaccines, Miami, FL, USA, March 1-3, 2010.Antigenicity of the 2015-2016 seasonal H1N1 human influenza virus HA and NA proteins.Anti-neuraminidase antibodies against pandemic A/H1N1 influenza viruses in healthy and influenza-infected individuals.
P2860
Q23921202-D0DB1540-1632-4B1F-B5FA-2C94622D7CB0Q28387782-BD1B135C-8C91-4DD3-81F8-7C26BB058B9BQ28547305-081BE48A-B20D-484D-9418-1B4EB3A02D4AQ30196901-D26B9A97-08B3-485C-B3CF-E672EC9C49F2Q30356053-60F15F07-71FA-497D-AF12-0A221AAD8A28Q30365079-9F11C75E-C53A-44E7-AA9D-93341CE69520Q30373917-625DB154-519E-48AD-9F2D-E4BF0BA662E2Q30374446-6250B3C1-EB7C-4821-AEFE-69458DEE9992Q30382921-4FF73B69-DE01-41D6-B3DA-0A0DF6B57ABCQ30385397-1E96D036-891B-464D-8DA4-F4127BCADEAEQ30401669-517F41D5-890D-4290-ABDE-43C5852002DFQ30406656-3D15C1F6-8ECC-435D-9429-6E00CD939812Q30407834-06CE0105-381D-4818-9E34-7593C123C21AQ30413023-787D6681-91D9-45A2-8E1C-3A4D89C55000Q30425378-CDB73F91-E22E-4A22-8C10-226EE1A12298Q30425783-584F46E9-1E70-4A1C-B708-567A4FF1C259Q30429009-9E51448F-2C0E-4C75-BB9A-53EF9FF3631CQ33592225-34462A44-056D-43BC-B159-00DB08116813Q33782762-8324E07C-4DC7-43A6-B7D9-5AD5CFE83129Q34194336-E5F53368-6850-44D5-9F2B-07F18762A72DQ34291098-936485A8-E315-4FFA-A28F-068237B1313AQ35408014-C7ADFBD9-61FA-4908-8D09-F85AFF39799BQ35715694-B9FA3CDE-B76A-46CF-AD44-B4C880396A7DQ35744237-60E6E78A-30D8-49B5-8CE7-D32DDB5DA645Q35791130-618A659C-1F6E-40C7-84C6-52B161B2810CQ35826733-9815D307-93D9-4098-A496-BC53CE4C5F38Q35897924-AC36CB51-5712-4DC6-B2A0-714A82E11F0CQ36075789-58D26B6C-2981-4AA1-8CE8-0BE5451B56ECQ36421986-DC378111-4A99-46EC-B247-657DEB6C8962Q36462309-C4E202A0-2EEF-43EB-A4BF-3D65698C7008Q38014839-734930FF-6D65-479C-9E1A-DC07F60C9240Q38105339-2EA03B5D-5EE4-429C-A3DB-1567FE5BC76FQ38852557-91B3EB52-7AD1-4664-844B-DD43F98BE160Q40459715-D9A08AED-32CE-4EBD-88B1-5100B6156D3DQ40523208-81F7BFAB-440F-4B41-B381-B2B9002163F6Q42870699-E0E9CB79-4473-4106-8C4D-BBD727A7FEEEQ43186538-4A817007-6716-4779-9684-7DD7590ECF0BQ45324745-0BD0A997-B7EB-46F0-9A33-95DCF1C67906Q54217203-31CCD795-36D9-400D-B8AE-610E1A084BB9
P2860
Measurement of anti-influenza neuraminidase antibody using a peroxidase-linked lectin and microtitre plates coated with natural substrates.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh-hant
name
Measurement of anti-influenza ...... oated with natural substrates.
@en
Measurement of anti-influenza ...... oated with natural substrates.
@nl
type
label
Measurement of anti-influenza ...... oated with natural substrates.
@en
Measurement of anti-influenza ...... oated with natural substrates.
@nl
prefLabel
Measurement of anti-influenza ...... oated with natural substrates.
@en
Measurement of anti-influenza ...... oated with natural substrates.
@nl
P2093
P1476
Measurement of anti-influenza ...... oated with natural substrates.
@en
P2093
Greffard A
Terzidis H
Webster RG
P356
10.1016/0022-1759(90)90255-T
P577
1990-12-01T00:00:00Z